- (2024): Hamidi S+, Thyroid Dec, Online ahead of print39%
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
Loading more results
No more results to show
Adverse reactions attributed to entire drug class 'RET (Rearranged during Transfection) kinase inhibitor'
Please login to view adverse reactions.
- (2025): Riya IJ+, Endocr Relat Cancer May, Online ahead of print16% (≥ grade 3) [REVIEW]
- (2024): Hamidi S+, Thyroid Dec, Online ahead of print26%
QT interval prolonged / QT prolongation
- (2024): Hamidi S+, Thyroid Dec, Online ahead of print39%
Alanine aminotransferase (ALT) increased
- (2025): Riya IJ+, Endocr Relat Cancer May, Online ahead of print11% (≥ grade 3) [REVIEW]
- (2024): Hamidi S+, Thyroid Dec, Online ahead of print48%
Aspartate aminotransferase (AST) increased
- (2025): Riya IJ+, Endocr Relat Cancer May, Online ahead of print6% (≥ grade 3) [REVIEW]
- (2024): Hamidi S+, Thyroid Dec, Online ahead of print26%
- (2025): Meng Z+, Clin Epidemiol 17, 87-104 [REVIEW] (association) (pharmacovigilance / pharmacoepidemiology)
- (2025): Riya IJ+, Endocr Relat Cancer May, Online ahead of print3% (≥ grade 3) [REVIEW]
- (2023): Ke JY+, Invest New Drugs Aug, Online ahead of print13% (grade 3–4) [REVIEW]
Neutropenia (neutrophils decreased)
- (2023): Ke JY+, Invest New Drugs Aug, Online ahead of print13% (grade 3–4) [REVIEW]
- (2024): Hamidi S+, Thyroid Dec, Online ahead of print35%
